Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +8.8% | +618.1% | 3 / 3 | -31.5% | +15.16 pp | +2.23 pp | +11.9% | 0.00 | 15.12 | 73,5 | −31,5% | 1,8 | +907,1% | 15.12 | -93.78 | — |
| Pts | 0 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 23.500 (close price on 2026-10-19)EPS (TTM): 1.555
Financial charts
1.Revenue & growth
VND bn73,5Q2/26
1.Revenue & growth
VND bn73,5Q2/26
2.Profit & growth
VND bn-2,07Q2/26
3.Profit mix (Penman)
VND bn87,9Q2/26
4.Margins & cost structure
%26.0%Q2/26
5.Returns & cash cycle
% · days-25.1%Q2/26
6.Earnings quality & cash
VND bn127Q2/26
7.Asset structure
VND bn825Q2/26
8.Funding & debt health
VND bn · times825Q2/26
9.Revenue backlog
VND bn42,6Q2/26
10.Valuation
times · %15,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-47Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
933%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26